Jonathan Davis

Director, ADC Discovery Helix Biopharma

Seminars

Monday 23rd February 2026
Next-Generation ADCs: Unlocking the Potential of CEACAM6-Directed Targeted Therapies
10:00 am
  • Examining CEACAM6 as a tumour-specific target in hard-to-treat solid tumours
  • Leveraging cutting edge ADC design to achieve precise targeting with broad therapeutic potential
  • Building state-of-the-art ADC constructs targeting CEACAM6
Jonathan Davis Speaker Photo - 16th World ADC London Summit